(1R,5S,8r)-3-(tert-Butoxycarbonyl)-3-azabicyclo[3.2.1]octane-8-carboxylic acid, 95%, 1g

3-Bromo-2-chloro-6-methyl-5-nitropyridine, 95.0%, 25g

4,4,4-Trifluoro-1-(2-methoxy-phenyl)-butane-1,3-dione, 10g

1-Isocyanato-2-nitrobenzene, 95.0%, 5g

2-[9,9-Dioctyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)fluoren-2-yl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 5g

4'-carboethoxy-3-(3-fluorophenyl)propiophenone, 97.0%, 1g

3-(2-{[(4-methoxyphenyl)sulfonyl]amino}-1,3-thiazol-4-yl)propanoic acid, 95.0%, 250mg

3-(3-(Trifluoromethyl)-3H-diazirin-3-yl)benzoic acid, 97%, 250mg

3,4-Dihydro-2H-1,4-benzothiazine, 95.0%, 100mg

Narrow mouth bottle 301, 2000 ml, 28 mm, 1 Piece

2-methylimidazo[1,2-a]pyridine-8-carboxylic acid dihydrochloride hydrate, 95.0%, 250mg

2-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyrazine hydrochloride, 97%, 50mg

3,5-Dimethyl-1-(pyridin-3-ylmethyl)-1H-pyrazole-4-carboxylic acid, 1g